Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Federal Trade Commission
Accenture
Mallinckrodt
QuintilesIMS
Daiichi Sankyo
Argus Health
Boehringer Ingelheim

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021393

« Back to Dashboard

NDA 021393 describes ADVIL PM, which is a drug marketed by Pfizer and is included in two NDAs. It is available from three suppliers. There are three patents protecting this drug and two Paragraph IV challenges. Additional details are available on the ADVIL PM profile page.

The generic ingredient in ADVIL PM is diphenhydramine citrate; ibuprofen. There are twenty-three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.
Summary for 021393
Tradename:ADVIL PM
Applicant:Pfizer
Ingredient:diphenhydramine hydrochloride; ibuprofen
Patents:2
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021393
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393 NDA Pfizer Consumer Healthcare 0573-0167 N 0573-0167-25
ADVIL PM diphenhydramine hydrochloride; ibuprofen CAPSULE;ORAL 021393 NDA Pfizer Consumer Healthcare 0573-0167 N 0573-0167-26

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:CAPSULE;ORALStrength25MG;EQ 200MG FREE ACID AND POTASSIUM SALT
Approval Date:Dec 21, 2005TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Jan 17, 2022Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD OF TREATING A PATIENT SUFFERING FROM A PAIN ASSOCIATED SLEEP DISTURBANCE COMPRISING ADMINISTERING A LIQUID COMPOSITION FORMULATED INSIDE A SOFT GEL CAPSULE, AS CLAIMED, TO THE PATIENT
Patent:➤ Try a Free TrialPatent Expiration:Jan 17, 2022Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Covington
Daiichi Sankyo
Dow
Johnson and Johnson
QuintilesIMS
Julphar
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.